Whitehawk Therapeutics, Inc. (WHWK) has 12 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 15, 2026 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | $0 | 236,952 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 15, 2026 | Dornan David Chief Scientific Officer | $0 | 171,774 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 15, 2026 | BALL BRYAN See remarks | $0 | 183,266 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 15, 2026 | Lennon David James CHIEF EXECUTIVE OFFICER | $0 | 387,914 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 15, 2026 | Dugan Margaret Chief Medical Officer | $0 | 162,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free